Back to search

Article

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

2020-06-26

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Oncolytic virotherapy is an upcoming treatment option for many tumor entities. But so far, a first oncolytic virus only was approved for advanced stages of malignant melanomas. Neuroendocrine tumors (NETs) constitute a heterogenous group of tumors arising from the neuroendocrine system at diverse anatomic sites. Due to often slow growth rates and (in most cases)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e2621f0-43a3-56e9-83c3-43cfece3774c
DOI
10.21203/rs.2.20785/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasmsDOI 10.21203/rs.2.20785/v3
Select a neighboring publication to make it the new centre.